Lilly: 1Q Earnings Snapshot
Eli Lilly and Co. (LLY) on Tuesday reported first-quarter net income of $1.22 billion, after reporting a loss in the same period a year earlier.
Express Scripts’ plan to change drug pricing dynamic
Express Scripts wants to change the pricing model for prescription drugs.
Artificial intelligence company sees 21st century breakthroughs
C3 IoT looks to transform fields including agriculture and healthcare.
Feds widen safety probes of Ford, VW and Nissan vehicles
The U.S. government's highway safety agency is expanding three investigations for brake and air bag troubles that could affect more than 2.3 million vehicles from Ford, Volkswagen and Nissan.
Markets Right Now: Stocks end lower after early gain fades
The latest on developments in financial markets (all times local): 9:35 a.m.
Germany's Fresenius, US-based Akorn at odds over merger deal
Germany's Fresenius and U.S.-based pharmaceutical manufacturer Akorn Inc. are at odds over the German company's decision to terminate a more than $4.3 billion takeover agreement, citing alleged breaches of data integrity requirements.
Recalls this week: electrical safety switches, toys
More than 1 million electrical safety switches are being recalled because of a faulty switch.
Decline in doctors prescribing opioids
America's opioid crisis
Shire rejects Takeda’s $63 billion offer
Takeda shares fall after Shire rejects $63 billion offer.
Woman's win of nursing home money a rarity in aging Japan
When her stay at the glamorous Grancreer residence turned into a nightmare of disrupted sleep and difficulties with the staff, retired harpist Yumi Makino opted out, and after a two-year legal battle got her deposit money back in a rare victory over a big real estate company.
US experts back marijuana-based drug for childhood seizures
A panel of government health advisers is recommending approval of a medicine made from the marijuana plant to treat childhood epilepsy, moving the medication closer to the U.S. market.
Procter & Gamble pays $4.2 bln for unit of Germany's Merck
German pharmaceutical and chemical company Merck says it has agreed to sell its global consumer health business to Procter & Gamble for 3.4 billion euros ($4.2 billion) in cash.
Procter & Gamble acquires Merck's consumer health business for about $4.21 billion
P&G adds consumer health products from Germany's Merck for $4,21 billion.
Dr. Marc Siegel on 'comfort care:' Barbara Bush is a pioneer
Remembering Barbara Bush
Ford uses van service to enter medical transport business
Ford is getting into the non-emergency medical transportation business as it moves toward making money off its experimental ventures in new mobility.
Marijuana-based drug gets positive review from US agency
U.S. health officials say a closely watched medicine made from the marijuana plant significantly reduces seizures in children with severe forms of epilepsy and warrants approval in the country.
US regulators float ideas for boosting medical device safety
U.S. health officials are considering new steps to improve the government's system for overseeing medical devices.
Opioid epidemic: Bernie Sanders introducing bill targeting opioid manufacturers
Sanders, an independent who ran for the Democratic presidential nomination in 2016, said the bill aimed to hold opioid manufacturers accountable for their role in the epidemic and force them to help pay for the crisis.
Johnson & Johnson tops 1Q views on sales spike, but net dips
Johnson & Johnson is reporting better than expected profit and revenue for the first quarter The New Brunswick, New Jersey, company on Tuesday reported profits of $4.37 billion, or $1.60 per share.
UnitedHealth hikes 2018 forecast, books another big 1Q gain
UnitedHealth Group is reporting first-quarter earnings of $2.84 billion, a jump of more than 30 percent from last year, with broad growth for the nation's largest health insurer.













